Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma, Large B-Cell, Diffuse
×
utomilumab
×
Clear all
Filters
3
NCT02951156
2020-12-17
Javelin DLBCL
Pfizer
Phase 3
Terminated
29 enrolled
24 charts